Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Murray

Showing results (241-250 of 265) with videos related to

Pageof 27
Sort By:
The Journal of Biological Chemistry|March 11, 2004
Manipulation of alternative splicing by a newly developed inhibitor of ClksMichiko Muraki, Bisei Ohkawara, Takamitsu Hosoya, et al.
Psychiatric Genetics|August 30, 2001
Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorderR S Devon, S Anderson, P W Teague, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2018
Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetesMichael P Winters, Zhihua Sui, Mark Wall, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2018
Erratum to "Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetes" Bioorg. Med. Chem. Lett. 28 (2018) [841-846]Michael P Winters, Zhihua Sui, Mark Wall, et al.
Journal of Medicinal Chemistry|March 18, 2005
Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 inhibitorsGee-Hong Kuo, Aihua Wang, Stuart Emanuel, et al.
Journal of Medicinal Chemistry|June 25, 2005
1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors: synthesis and evaluation of biological activitiesRonghui Lin, Peter J Connolly, Shenlin Huang, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2009
Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsRonghui Lin, Sigmond G Johnson, Peter J Connolly, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2014
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogsShyh-Ming Yang, Yuting Tang, Thomas Rano, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 16, 2010
Syndromic surveillance to assess the potential public health impact of the Icelandic volcanic ash plume across the United Kingdom, April 2010A J Elliot, N Singh, P Loveridge, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
7-(4-Alkylidenylpiperidinyl)-quinolone bacterial topoisomerase inhibitorsEugene B Grant, Barbara D Foleno, Raul Goldschmidt, et al.
Pageof 27

Showing results (241-250 of 265) with videos related to

Sort By:
Pageof 27
The Journal of Biological Chemistry|March 11, 2004
Manipulation of alternative splicing by a newly developed inhibitor of ClksMichiko Muraki, Bisei Ohkawara, Takamitsu Hosoya, et al.
Psychiatric Genetics|August 30, 2001
Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorderR S Devon, S Anderson, P W Teague, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2018
Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetesMichael P Winters, Zhihua Sui, Mark Wall, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2018
Erratum to "Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetes" Bioorg. Med. Chem. Lett. 28 (2018) [841-846]Michael P Winters, Zhihua Sui, Mark Wall, et al.
Journal of Medicinal Chemistry|March 18, 2005
Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 inhibitorsGee-Hong Kuo, Aihua Wang, Stuart Emanuel, et al.
Journal of Medicinal Chemistry|June 25, 2005
1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors: synthesis and evaluation of biological activitiesRonghui Lin, Peter J Connolly, Shenlin Huang, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2009
Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsRonghui Lin, Sigmond G Johnson, Peter J Connolly, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2014
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogsShyh-Ming Yang, Yuting Tang, Thomas Rano, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 16, 2010
Syndromic surveillance to assess the potential public health impact of the Icelandic volcanic ash plume across the United Kingdom, April 2010A J Elliot, N Singh, P Loveridge, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
7-(4-Alkylidenylpiperidinyl)-quinolone bacterial topoisomerase inhibitorsEugene B Grant, Barbara D Foleno, Raul Goldschmidt, et al.
Pageof 27